Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6165225rdf:typepubmed:Citationlld:pubmed
pubmed-article:6165225lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:6165225lifeskim:mentionsumls-concept:C1522449lld:lifeskim
pubmed-article:6165225lifeskim:mentionsumls-concept:C0220641lld:lifeskim
pubmed-article:6165225lifeskim:mentionsumls-concept:C0005740lld:lifeskim
pubmed-article:6165225lifeskim:mentionsumls-concept:C0445550lld:lifeskim
pubmed-article:6165225lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:6165225pubmed:issue6lld:pubmed
pubmed-article:6165225pubmed:dateCreated1981-7-20lld:pubmed
pubmed-article:6165225pubmed:abstractTextSeven patients with advanced oral carcinoma have been given 1 Gy per irradiation up to total dose 74 to 81 Gy. Bleomycin was given intramuscularly before irradiation. The therapeutic ratio of the proposed scheme was good. The early reactions were severe but were managed by a split course technique. No late complication occurred. All patients were tumour-free 18 to 54 months after treatment. A relapse occurred only in one case. The results are not conclusive, but bearing in mind that the results in advanced oral carcinoma are poor they suggest that the proposed treatment regime may be promising.lld:pubmed
pubmed-article:6165225pubmed:languageenglld:pubmed
pubmed-article:6165225pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6165225pubmed:citationSubsetIMlld:pubmed
pubmed-article:6165225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6165225pubmed:statusMEDLINElld:pubmed
pubmed-article:6165225pubmed:issn0349-652Xlld:pubmed
pubmed-article:6165225pubmed:authorpubmed-author:LittbrandBBlld:pubmed
pubmed-article:6165225pubmed:authorpubmed-author:LöfrothP OPOlld:pubmed
pubmed-article:6165225pubmed:authorpubmed-author:LindholmCClld:pubmed
pubmed-article:6165225pubmed:issnTypePrintlld:pubmed
pubmed-article:6165225pubmed:volume19lld:pubmed
pubmed-article:6165225pubmed:ownerNLMlld:pubmed
pubmed-article:6165225pubmed:authorsCompleteYlld:pubmed
pubmed-article:6165225pubmed:pagination417-20lld:pubmed
pubmed-article:6165225pubmed:dateRevised2006-12-5lld:pubmed
pubmed-article:6165225pubmed:meshHeadingpubmed-meshheading:6165225-...lld:pubmed
pubmed-article:6165225pubmed:meshHeadingpubmed-meshheading:6165225-...lld:pubmed
pubmed-article:6165225pubmed:meshHeadingpubmed-meshheading:6165225-...lld:pubmed
pubmed-article:6165225pubmed:meshHeadingpubmed-meshheading:6165225-...lld:pubmed
pubmed-article:6165225pubmed:meshHeadingpubmed-meshheading:6165225-...lld:pubmed
pubmed-article:6165225pubmed:meshHeadingpubmed-meshheading:6165225-...lld:pubmed
pubmed-article:6165225pubmed:meshHeadingpubmed-meshheading:6165225-...lld:pubmed
pubmed-article:6165225pubmed:meshHeadingpubmed-meshheading:6165225-...lld:pubmed
pubmed-article:6165225pubmed:meshHeadingpubmed-meshheading:6165225-...lld:pubmed
pubmed-article:6165225pubmed:year1980lld:pubmed
pubmed-article:6165225pubmed:articleTitleSuperfractionated irradiation combined with low doses of bleomycin in the treatment of oral carcinoma.lld:pubmed
pubmed-article:6165225pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6165225pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed